FDA Adverse Event Injury Summary report: N

KINETRA

MDR report key: 2990969 · Received March 6, 2013

Report

Report Number
3007566237-2013-00686
Event Type
Injury
Date Received
March 6, 2013
Report Date
March 25, 2013
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

FOLLOW UP INFORMATION REPORTED THAT THE PATIENT'S DERMATOLOGIST BELIEVED THAT THE PATIENT DID NOT HAVE AN ALLERGY OR AN INFECTION. THE PHYSICIAN PLANNED TO DO SOME ALLERGY TESTS SOON.

Description of Event or Problem · 1

IT WAS FURTHER REPORTED THAT THE SYMPTOMS WERE REDNESS, PAIN AND ITCHING AT THE SITE OF IMPLANT. THERE WERE NO SIGNS OF INFECTION OR SWELLING. THE AREA RESPONDED TO ANTIHISTAMINES. THE SURGEON DID NOT TAKE ANY TISSUE SAMPLES. THE SITE OF IMPLANT WAS CHANGED (B)(6) 2011 AND AGAIN IN (B)(6) 2012. ALLERGY TESTS WERE SUGGESTED. AN OUTCOME WAS NOT PROVIDED. IF RECEIVED, A FOLLOW UP REPORT WILL BE SENT.

Description of Event or Problem · 1

IT WAS REPORTED THAT THERE HAD BEEN AN ALLERGIC REACTION/EROSION. AN INFLAMMATORY REACTION AT THE IMPLANTABLE NEUROSTIMULATOR (INS) SITE WAS NOTED WITHOUT ANY LOCALIZED INFECTION. IT WAS UNCLEAR IF THIS WAS AN ALLERGY TO THE INS MATERIAL. IT WAS STATED THAT THE INS SITE HAD BEEN CHANGED 3 TIMES OVER THE PAST 18 MONTHS AND THE INFLAMMATORY RESPONSE CAME BACK EACH AND EVERY TIME. PATIENT STATUS AT THE TIME OF THIS REPORT WAS NOT POSSIBLE TO BE OBTAINED. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT WAS NOT AVAILABLE AS OF THE DATE OF THIS REPORT. WHEN RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
96066 KINETRA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION 7428

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention